Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
First, there is a single standards name, which is risankizumab for Skyrizi. That name stays the same regardless of what companies make or market the drug.
"Skyrizi" is a brand name, chosen by some marketing folks at AbbVie. They could decide to market it under another brand name. Once it is off-patent and other companies market it also, they will choose their own brand names.
Edit history
Please sign in to view edit histories.
Recommendations
0 members have recommended this reply (displayed in chronological order):
10 replies
= new reply since forum marked as read
= new reply since forum marked as read